Möhn N - Search Results

1

Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases.

Möhn N, Konen FF, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T. Möhn N, et al. J Clin Med. 2020 Dec 16;9(12):4067. doi: 10.3390/jcm9124067. J Clin Med. 2020. PMID: 33339436 Free PMC article. Review.

2

[Neurological complications of infections with (novel) enteroviruses].

Möhn N, Skripuletz T, Stangel M. Möhn N, et al. Nervenarzt. 2018 Dec;89(12):1320-1331. doi: 10.1007/s00115-018-0619-9. Nervenarzt. 2018. PMID: 30259057 Review. German.

3

Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.

Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs KW, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, Alvermann S, Schmidt RE, Stangel M, Jacobs R, Skripuletz T. Gingele S, et al. Among authors: mohn n. Cells. 2018 Dec 28;8(1):12. doi: 10.3390/cells8010012. Cells. 2018. PMID: 30597851 Free PMC article.

4

Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanoma.

Möhn N, Sühs KW, Gingele S, Angela Y, Stangel M, Gutzmer R, Satzger I, Skripuletz T. Möhn N, et al. Melanoma Res. 2019 Aug;29(4):435-440. doi: 10.1097/CMR.0000000000000598. Melanoma Res. 2019. PMID: 30855529

5

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics.

Bönig L, Möhn N, Ahlbrecht J, Wurster U, Raab P, Puppe W, Sühs KW, Stangel M, Skripuletz T, Schwenkenbecher P. Bönig L, et al. Among authors: mohn n. Front Neurol. 2019 Aug 20;10:839. doi: 10.3389/fneur.2019.00839. eCollection 2019. Front Neurol. 2019. PMID: 31481919 Free PMC article.

6

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Möhn N, Luo Y, Skripuletz T, Schwenkenbecher P, Zerr I, Lange P, Stangel M. Möhn N, et al. Fluids Barriers CNS. 2019 Sep 5;16(1):28. doi: 10.1186/s12987-019-0148-3. Fluids Barriers CNS. 2019. PMID: 31484537 Free PMC article.

7

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.

Möhn N, Beutel G, Gutzmer R, Ivanyi P, Satzger I, Skripuletz T. Möhn N, et al. J Clin Med. 2019 Oct 24;8(11):1777. doi: 10.3390/jcm8111777. J Clin Med. 2019. PMID: 31653079 Free PMC article. Review.

8

Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF.

Möhn N, Pfeuffer S, Ruck T, Gross CC, Skripuletz T, Klotz L, Wiendl H, Stangel M, Meuth SG. Möhn N, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Dec 11;7(2):e654. doi: 10.1212/NXI.0000000000000654. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31826986 Free PMC article.

9

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab.

Möhn N, Skripuletz T, Sühs KW, Menck S, Voß E, Stangel M. Möhn N, et al. Ther Adv Neurol Disord. 2019 Dec 2;12:1756286419887596. doi: 10.1177/1756286419887596. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31832100 Free PMC article.

10

Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome.

Stahl K, Schmidt BMW, Hoeper MM, Skripuletz T, Möhn N, Beutel G, Eder M, Welte T, Ganser A, Falk CS, Koenecke C, David S. Stahl K, et al. Among authors: mohn n. J Crit Care. 2020 Jun;57:124-129. doi: 10.1016/j.jcrc.2020.02.010. Epub 2020 Feb 19. J Crit Care. 2020. PMID: 32113143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page